Riskpilot← Back to searchSign inGet full accessKOREN OPTIKK AS
ASActiveOrg 990879753Kuben Kjøpesenter, 7100 RissaRetail sale of medical and orthopaedic goods · NACE 4774Est. 20074 employees
Revenue 2024
NOK 6,2M
+12% vs 2023
EBITDA margin
19.5%
+22% vs 2023
Equity ratio
73.4%
Financial strength
Net profit 2024
NOK 963K
+22% vs 2023
| Revenue | NOK 6,2M | +12% |
| EBITDA | NOK 1,2M | +22% |
| Net profit | NOK 963K | +22% |
| Total assets | NOK 4M | +12% |
| Equity | NOK 2,9M | +14% |
| Employees | 4 | — |
Legal name
KOREN OPTIKK AS
Org number
990879753
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. mars 2007
Share capital
NOK 200 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Company purpose
Handel og servicevirksomhet og hva dermed står i forbindelse.
Address
Kuben Kjøpesenter, 7100 Rissa
Phone
+4773505010
Email
post@koren-optikk.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 428 | 4 873 | 5 107 | 5 565 | 6 245 |
| Staff expenses | −1 970 | −1 797 | −1 882 | −2 044 | −2 234 |
| EBITDA | 319 | 802 | 968 | 999 | 1 220 |
| Depreciation & amort. | −114 | −81 | −57 | −39 | −48 |
| EBIT | 205 | 721 | 911 | 960 | 1 172 |
| Net financials | 28 | 15 | 32 | 53 | 58 |
| Profit before tax | 233 | 736 | 943 | 1 013 | 1 230 |
| Tax | 54 | 160 | 204 | 222 | 267 |
| Net profit | 179 | 576 | 739 | 791 | 963 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 468 | 2 942 | 3 317 | 3 579 | 4 011 |
| Equity | 1 827 | 2 103 | 2 392 | 2 583 | 2 946 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 641 | 840 | 926 | 996 | 1 065 |
| Total debt | 641 | 840 | 926 | 996 | 1 065 |
EBITDA margin
19.5%
This company
15.8%
Market median
+23% vs market
20202024
Equity ratio
73.4%
This company
38.2%
Market median
+92% vs market
20202024
Return on equity
32.7%
This company
18.4%
Market median
+78% vs market
20202024
Net profit margin
15.4%
This company
8.1%
Market median
+90% vs market
20202024
Asset turnover
1.56×
This company
1.12×
Market median
+39% vs market
20202024
Debt / equity
0.36×
This company
0.62×
Market median
+42% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
SL Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2021 | |
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 33.35% | 33.35% | 2023 | |
| Company | 33.35% | 33.35% | 2023 | |
| Company | 33.3% | 33.3% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Msv As
KOREN OPTIKK AS Board members of KOREN OPTIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Signe Lise Tung Nilsen | Chief Executive Officer | 0 companies |
| Kristin Solli Kristiansen | Board of Directors | 0 companies |
| Ståle Mosand Viken | Chairman | 0 companies |